On 12/10/24, CASI Pharmaceuticals Inc (NASDAQ: CASI) stock suffered a major decline of -11.8%, closing at $3.43. Moreover, this decline was accompanied by unusually high trading volume at 179% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -13.1% during the last week.
Current PriceTarget Research Rating
CASI Pharmaceuticals has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CASI Pharmaceuticals has a very low Appreciation Score of 11 but a very high Power Rating of 93, leading to the Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment